Drug control in Belgium: a brief history of drug laws (drugs for human use)
Oslet, J.
Journal de Pharmacie de Belgique 62(4): 123-129
2007
ISSN/ISBN: 0047-2166 PMID: 18269140 Document Number: 612468
Document emailed within 1 workday
Related Documents
Fox, D.M. 1991: History of drug use and drug control Mount Sinai Journal of Medicine new York 58(5): 403-405; Discussion: 437-442Schleifer, R.; Pol, L. 2017: International Guidelines on Human Rights and Drug Control: A Tool for Securing Women's Rights in Drug Control Policy Health and human rights 19(1): 253-261
Titti, F.; Lazzarin, A.; Costigliola, P.; Oliva, C.; Nicoletti, L.; Negri, C.; Ricchi, E.; Donati, G.; Uberti-Foppa, C.; Re, M.C. 1987: Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in I.v. drug addicts in Italy Journal of Medical Virology 23(3): 241-248
Titti, F.; Lazzarin, A.; Costigliola, P.; Oliva, C.; Nicoletti, L.; Negri, C.; Ricchi, E.; Donati, G.; Uberti-Foppa, C.; Re, M.C. 1987: Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in I.v. drug addicts in Italy Journal of Medical Virology 23(3): 241-248
Méroz, J.C. 1991: Intercantonal Office for Drug Control. Its history, activities, current problems Revue Medicale de la Suisse Romande 111(11): 951-954
Joss, R.A.; Brand, B.C.; Buser, K.S.; Cerny, T. 1990: The symptomatic control of cytostatic drug-induced emesis. a recent history and review European Journal of Cancer 26(Suppl 1): S2-S8
Goldman, R.C.; Plumley, K.V.; Laughon, B.E. 2007: The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control Infectious Disorders Drug Targets 7(2): 73-91
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Kigen, G.; Kimaiyo, S.; Nyandiko, W.; Faragher, B.; Sang, E.; Jakait, B.; Owen, A.; Back, D.; Gibbons, S.; Seden, K.; Khoo, S.H.; Nyandiko, W.; Wools-Kaloustian, K.; Kimaiyo, S.; Braitstein, P.; Sang, E.; Jakait, B.; Pastakia, S. 2011: Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort Plos one 6(2): E16800
Krácmar, J.; Sotolongo, M.A.; Krácmarová, J. 1978: UV spectrophotometry in drug control. 22. Spectrophotometric determination of drugs with benzol chromophor Die Pharmazie 33(10): 659-663
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Venho, V.M.; Palva, E.S.; Konno, K.; Stenfors, E. 1987: The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate Methods and Findings in Experimental and Clinical Pharmacology 9(7): 445-447
Krácmar, J.; Alvarez, M.; Lastovková, M.; Krácmarová, J. 1975: Ultraviolet spectrophotometry in drug control. 17. Comparison of drugs with sulfonamide- and benzene chromophores Die Pharmazie 30(7): 447-450
Lee, J. 2014: Assessing drug value. Hospitals take steps to control drug costs and aid patients Modern Healthcare 44(48): 22; 24-25
Arneson, H.T.; Colton, R.S. 1987: Drug-drug interaction with the use of antirheumatic drugs Minnesota Medicine 70(10): 589; 592
Huttunen, M.O. 1998: On drugs, drug users and drug policy Duodecim; Laaketieteellinen Aikakauskirja 114(20): 2100-2102
Zessin, G.; Fahr, F.; Mank, R. 1986: The control of drug release of heavy-soluble, weak basic drugs in matrix tablets using the example of medazepam Die Pharmazie 41(1): 39-42
Niaz, K. 2017: International drug control system and the United Nations General Assembly Special Session (UNGASS) on the world drug problem: an overview Eastern Mediterranean Health Journal 23(3): 143-149